Intestinal Failure and Parenteral Support
Research activity in intestinal failure centers on patients requiring long-term parenteral support, with attention to nutritional replacement and the management of choline deficiency-related needs.
- Choline Chloride for Injection
- Plasma free choline concentration
- Safety and tolerability
The clinical focus includes pharmacokinetic assessment and the role of choline supplementation in adolescent and adult populations with chronic intestinal absorption limitations.
Non-muscle Invasive Bladder Cancer
In non-muscle invasive bladder cancer, the sponsor is involved in intravesical oncology research for adults with high-grade disease, with emphasis on local tumor control within the bladder.
- TARA-002 intravesical therapy
- Bladder biopsy and cystoscopy
- Urine cytology
The therapeutic interest extends to preliminary and anti-tumor activity assessments in a bladder-directed setting, reflecting a focus on localized urologic oncology.
Clinical Pharmacology
Across its studies, the sponsor engages in clinical pharmacology with measurement of circulating analytes and treatment-related exposure profiles, supporting evaluation of biologic activity in both nutritional and oncologic contexts.
- Rich PK sampling
- Double-blind and open-label assessment
- Source of choline evaluation
This area links systemic biomarker monitoring with therapeutic development in metabolic support and bladder-directed treatment.
Adult and Adolescent Care
The research portfolio includes both adolescent and adult patients, indicating interest in therapies relevant to broader age groups affected by chronic gastrointestinal disease and bladder cancer.
- Long-term disease management
- Supportive care
- Localized treatment delivery
These studies connect chronic care needs with targeted therapeutic delivery in settings where ongoing treatment is clinically important.
